Henry Schein Reports Strong First Quarter 2025 Financial Results, Reaffirms Full-Year Guidance Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions for office-based dental and medical practitioners, has announced its financial results for the first quarter ended…
ImmunityBio Requests Urgent FDA Meeting After Refusal to File sBLA for ANKTIVA in NMIBC Papillary Disease, Citing Sudden Reversal from January Guidance ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company focused on developing therapies for difficult-to-treat cancers and infectious diseases,…
Modivcare Announces Executive Leadership Transitions Amid Strategic Business Model Evolution Modivcare Inc. (Nasdaq: MODV), a leading technology-enabled healthcare services company focused on delivering supportive care solutions that address social determinants of health, today announced the planned departures of two key…
TAE Life Sciences and Ohio State Forge Landmark Partnership to Advance Boron-Based Precision Cancer Therapies In a significant leap forward for precision oncology, TAE Life Sciences (TLS), a pioneer in accelerator-based cancer treatment technologies, has announced a transformative collaboration with…
Emmy-Winning Series Unveils Trailer for Shelter Me: The Cancer Pioneers, a Moving Documentary on Dogs Leading the Fight Against Cancer The Emmy Award-winning Shelter Me series has released the official trailer for its newest and most impactful installment yet: Shelter…
HAYA Therapeutics to Present Breakthroughs in RNA-Guided Regulatory Genome Platform at 2025 ASGCT Annual Meeting HAYA Therapeutics, SA, a biotechnology company at the forefront of developing precision RNA-guided therapeutics that reprogram pathogenic cell states, announced today its participation at the…
Immunome Grants Equity Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) as Part of Talent Expansion Strategy Immunome, Inc. (Nasdaq: IMNM), a clinical-stage biotechnology company pioneering innovative cancer therapies with a focus on first-in-class and best-in-class antibody-based treatments, announced…
Astria Therapeutics Grants Stock Options to New Employees Under Nasdaq Listing Rule 5635(c)(4) Astria Therapeutics, Inc. (Nasdaq: ATXS), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for allergic and immunologic diseases, has announced the granting of stock options to…
Aya Healthcare Appoints Emily Hazen as Chief Executive Officer, Ushering in a New Era of Innovation and Growth Aya Healthcare, the nation’s largest healthcare talent software and staffing company, has officially announced the appointment of Emily Hazen as its new…
UnitedHealthcare Community Plan of Arizona Selected to Continue Statewide Service for Long-Term Care Members Under ALTCS EPD Program The Arizona Health Care Cost Containment System (AHCCCS), the state’s Medicaid agency, has announced its intention to award a new contract to…
Fresenius Medical Care Celebrates 40 Years of Lifesaving Dialysis Services in Sokolov, Czech Republic In 2025, the dialysis center in Sokolov, located in the heart of western Bohemia, Czech Republic, is marking a significant milestone—its 40th anniversary. What began as…
Northwest Healthcare Properties REIT Receives Investment-Grade Credit Rating of BBB (Low) with Stable Trend from Morningstar DBRS Northwest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN), referred to as “Northwest” or “the REIT,” has announced a significant development in its…